Drug Discovery

Vaccine
#Clinical trials #Drug development #Funding #Immunology / Virology & Vaccines #Respiratory #Vicebio

New financing and clinical trial for RSV/hMOV bivalent vaccine

Vicebio has announced a $100 million Series B financing, which will be used to develop next-generation vaccines for respiratory viruses.   The development will utilise Vicebio’s Molecular Clamp technology, discovered at The University of Queensland. The technology stabilises viral glycoproteins in their highly immunogenic ‘prefusion’ conformation, crucial for… Read More

#News

Microbiome
#Drug development #Drug discovery #Mental health #Microbiome #Oncology

Hot off the press: Read the Fall issue of DDW now

The DDW Fall issue is out now and asks if the gut microbiome can unlock new therapeutics for mental health disorders, places a spotlight on oncology and includes a market report on the North American drug discovery hotspots. It also features an exclusive guide on… Read More

#Editor's Choice #News

#Drug discovery

Webinar: Building advanced cell models for toxicity testing – Lonza – 19.09.2024

Life sciences researchers need a host of tools to develop and test critical disease-treating drugs and therapies, from basic research to final product release. Primary cells, media, and reagents are all important for supporting preclinical and clinical pharmaceutical workflows for drug discovery and absorption, distribution, metabolism, excretion, and toxicity (ADMET)… Read More

#Webinars

#Amyotrophic lateral sclerosis (ALS) #CNS #Drug development #Drug discovery #Neuroscience #Webinar

What are the latest advancements driving neuroscience drug discovery?

In this webinar on 30 September, from 3-4PM BST, hosted by DDW and sponsored by ApconiX, you will hear from Dr Isaac Klein, Chief Scientific Officer at Dewpoint Therapeutics, Dr Sam Clark, CEO of Terran Biosciences, and Professor Ruth Roberts, Co-founder and Director of Safety Science at ApconiX. Read More

#News

New appointment
#Appointment #Career #Drug discovery #New appointment

C-level moves within drug discovery and development

We round-up the key senior career moves in the industry over the last few months. Emile Shaffu, Director of Sales, Newcells Biotech: Shaffu has over 20 years of international sales and management experience in the life sciences, most recently as UK Regional Business Manager at Bionano… Read More

#News

#AI #Career #Clinical trials #Drug discovery #Infectious diseases #Meet the Researcher #Oncology #Poolbeg Pharma

Meet the researcher: Liam Tremble

DDW’s Megan Thomas looks at a day in the life of Liam Tremble, Principal Scientist at Poolbeg Pharma. 1. Where do you work, and can you tell us what you’re working on at the moment?   I work at Poolbeg Pharma, where we are developing novel treatments… Read More

#Exclusive Content #Opinion

#Amyotrophic lateral sclerosis (ALS) #CNS #Drug development #Drug discovery #Neuroscience #Webinar

Webinar on driving neuroscience drug discovery research

In this webinar on 30 September, from 3-4PM BST, hosted by DDW and sponsored by ApconiX, you will hear from Dr Isaac Klein, Chief Scientific Officer at Dewpoint Therapeutics, Dr Sam Clark, CEO of Terran Biosciences, and Professor Ruth Roberts, Co-founder and Director of Safety Science at ApconiX. Read More

#News

Robot holds up a pill
#AI #BioXcel Therapeutics #Drug discovery #Drug repurposing

New podcast: Are we close to an AI drug revolution?

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Dr Friso Postma,… Read More

#News

Saline intravenous (iv) drip in a child's hand
#Cancer Research Horizons #Drug discovery #LifeArc #Oncology #Paediatrics

Research consortium to focus on drug discovery for paediatric cancers

With an initial investment of £28 million in resources and funding, LifeArc and Cancer Research UK have launched a new initiative to develop medicines exclusively for children’s and young people’s cancers. C-Further will bring together researchers, clinicians, scientists and industry to provide support, finance and expertise. Read More

#Cancer Research #News

#Amyotrophic lateral sclerosis (ALS) #CNS #Drug development #Drug discovery #Neuroscience #Webinar

The latest advancements driving neuroscience drug discovery

In this webinar on 30 September, from 3-4PM BST, hosted by DDW and sponsored by ApconiX, you will hear from Dr Isaac Klein, Chief Scientific Officer at Dewpoint Therapeutics, Dr Sam Clark, CEO of Terran Biosciences, and Professor Ruth Roberts, Co-founder and Director of Safety Science at ApconiX. Read More

#News

The Francis Crick Institute
#Drug discovery #Laboratory #Merck #MSD #The Francis Crick Institute #UK

Francis Crick and MSD boost UK drug research with new Skylab

The Francis Crick Institute and MSD have opened a new Skylab facility, extending the footprint of the Crick and expanding opportunities for collaboration between the two organisations. The new 11,800 square foot specialised life sciences laboratory is located on the roof space of the Crick and… Read More

#News

#Drug discovery #Therapeutic Antibodies

Webinar: Next-gen antibody discovery: Leveraging DNA immunisation and single B-cell cloning for high-affinity & specificity rabbit mAbs – FUJIFILM – 09.09.2024 DDW

Watch this engaging and informative webinar on Fujifilm Wako’s groundbreaking advancements in rabbit monoclonal antibody discovery. Traditional hybridoma technology has long struggled with inefficiencies, especially in producing rabbit monoclonal antibodies. Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with its proprietary single B-cell cloning technique, paving the way… Read More

#Webinars

High-throughput screening
#Assays #Cell / tissue culture #Cellular assays #Drug discovery #eBook #High throughput screening

Overcome the challenges of cell-based high-throughput screening

The tenth eBook of the Hamilton series is now available to download, entitled ‘Cell-Based High-Throughput Screening‘. The eBook covers: Cell-based models used in research – pros and cons. Challenges of cell-based high-throughput screening. Hamilton software and hardware tools for cell-based assays. Download now. Read More

#News

#Assays #Cell / tissue culture #Cellular assays #Drug discovery #High throughput screening

Cell-Based High-Throughput Screening

In the tenth eBook of the Hamilton series, ‘Cell-Based High-Throughput Screening’, we discuss: Cell-based models used in research – pros and cons. Challenges of cell-based high-throughput screening. Hamilton software and hardware tools for cell-based assays. Read More

#Resources

Brain physiology
#AGuIX #Cancer research #Clinical trial #Dana-Farber Cancer Institute #Drug discovery #Neuroscience

Phase II brain metastases trial advances after futility analysis 

The Phase II NANOBRAINMETS trial of AGuIX has been validated by the Data Safety and Monitoring Board (DSMB) following a futility analysis scheduled after the enrolment and follow-up of 50% of patients in the study.  The trial is being run by NH TherAguix, a biotechnology company developing… Read More

#Cancer Research #News